Filtered By:
Procedure: Electrocardiogram

This page shows you your search results in order of date. This is page number 15.

Order by Relevance | Date

Total 633 results found since Jan 2013.

Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease
CONCLUSIONS: Non-electrocardiogram-gated computed tomography during the initial pulmonary assessment of patients with COVID-19 without atherosclerotic cardiovascular disease showed a high prevalence of mild, moderate and heavy CAC. CAC score was related to 6-month mortality, independent of conventional cardiovascular risk factors. These results highlight the importance of CAC scoring for patients hospitalized with COVID-19, and calls for attention to patients with high CAC.PMID:35305915 | DOI:10.1016/j.acvd.2022.02.007
Source: Archives of Cardiovascular Diseases - March 20, 2022 Category: Cardiology Authors: Anne-Sophie Le Hir Antoine Fayol Elie Mousseaux Nicolas Danchin Victoria Tea Chekrallah Chamandi Gilles Soulat Etienne Puymirat Source Type: research

Findings From Cardiovascular Evaluation of National Collegiate Athletic Association Division I Collegiate Student-Athletes After Asymptomatic or Mildly Symptomatic SARS-CoV-2 Infection
Conclusions: These data support recent publications which recommend the de-escalation of cardiovascular testing such as cardiac MRI or echocardiogram for athletes who have recovered from asymptomatic or mildly symptomatic SARS-CoV-2 infection. Continued follow-up of these athletes for sequelae of SARS-CoV-2 is critical.
Source: Clinical Journal of Sport Medicine - March 1, 2022 Category: Sports Medicine Tags: Original Research Source Type: research

Electrocardiographic findings and mortality in Covid-19 patients hospitalized in different clinical settings.
Coronavirus-19 disease (Covid-19) is the definition issued by World Health Organization (WHO) to describe clinical manifestations caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection1-2. Covid-19 typically involves low respiratory tract infection causing interstitial pneumonia; multi-organ involvement however is not rare. In particular, cardiac involvement and acute myocardial injury have been shown to be associated with a worse prognosis3-4.
Source: Heart and Lung - February 24, 2022 Category: Intensive Care Authors: Marco Mele, Lucia Tricarico, Enrica Vitale, Andrea Favia, Francesca Croella, Simona Alfieri, Maria Delia Corbo, Federica Mango, Grazia Casavecchia, Natale Daniele Brunetti Source Type: research

Myocarditis following mRNA Covid-19 vaccination: A pooled analysis
CONCLUSIONS: Myocarditis following mRNA Covid-19 vaccination is typically mild, following an uncomplicated clinical course with rapid improvement of symptoms. Future research is needed to define its exact incidence, clarify its pathophysiology and determine the optimal management plan depending on its severity. Protocol registration: dx.https://doi.org/10.17504/protocols.io.bxwtppen.PMID:35153093 | DOI:10.1016/j.vaccine.2022.02.017
Source: Vaccine - February 14, 2022 Category: Allergy & Immunology Authors: Ioannis Bellos Vasilios Karageorgiou Dana Viskin Source Type: research

Evaluation of COVID-19–Associated Myocarditis Via Point-of-Care Ultrasound in a Pediatric Patient
Coronavirus disease 2019 (COVID-19)–associated myocarditis has been reported from the onset of the pandemic. The presumed etiology is direct damage to the myocardium from severe acute respiratory syndrome coronavirus 2. Common findings include electrocardiogram abnormalities, elevated cardiac markers, and diminished cardiac function. This can lead to heart failure and cardiogenic shock with resultant poor perfusion. Thus, myocarditis has been recognized as a cause of death in patients with COVID-19. Unfortunately, it is difficult to predict the prevalence of myocarditis in these patients given the relative novelty of the...
Source: Pediatric Emergency Care - February 1, 2022 Category: Emergency Medicine Tags: Ultrasound Case Review Source Type: research

Myocarditis and pericarditis after COVID-19 messenger RNA vaccines
Can Fam Physician. 2022 Jan;68(1):17-18. doi: 10.46747/cfp.680117.ABSTRACTQUESTION: With the approval of coronavirus disease 2019 (COVID-19) vaccine for children 5 to 11 years of age and concerns among parents in the past year following reported cases of myocarditis and pericarditis in adolescents, should my office continue to encourage all children and young adults to receive the COVID-19 messenger RNA vaccine?ANSWER: Since April 2021 reports have documented cases of myocarditis and pericarditis in adolescents and young adults after messenger RNA COVID-19 vaccination, and several hundred such reports were documented in Ca...
Source: Canadian Family Physician Medecin de Famille Canadien - January 22, 2022 Category: Primary Care Authors: Ran D Goldman Source Type: research